登入選單
返回Google圖書搜尋
Hepatitis C Virus
H. W. Reesink
出版Karger Medical and Scientific Publishers, 1998-07
主題Medical / Clinical MedicineMedical / Infectious DiseasesMedical / HematologyMedical / ImmunologyMedical / Internal MedicineMedical / MicrobiologyMedical / Hepatology
ISBN33180024969783318002492
URLhttp://books.google.com.hk/books?id=aNk3EQAAQBAJ&hl=&source=gbs_api
EBookSAMPLE
註釋Hepatitis C virus (HCV) is a chronic disease, which affects more than 170 million individuals, and the prevalence is growing. HCV is associated with significant mortality and morbidity and is transmitted by blood contact. Drug users, healthcare workers, and patients who require blood transfusions are at a higher risk to contract the disease. There is currently no vaccine available for HCV, and this paper investigates the scientific and social factors on the reason behind this. We investigate these various factors by performing a literature review on pubmed, national institutes of health (NIH), and various other sources on the internet. After a thorough evaluation of the available literature, we have found that there are currently no vaccines for HCV due to its inherent ability to mutate rapidly. HCV can thus negate stimulation of the immune system to mount an effective response. In addition, we have also discovered that there is very little funding for research and development of an effective vaccine. An HCV vaccine would be much more cost effective in comparison to current treatments available today. A prophylactic approach to this disease would be immensely beneficial globally, and would cater to the underserved population. Preventing spread of HCV could reduce costs of the healthcare system world wide.